Cumulative inflammatory burden and obesity as determinants of insulin resistance in patients with established rheumatoid arthritis: cross-sectional study
Open Access
Abstract
Objectives To describe the prevalence of insulin resistance (IR) in patients with established rheumatoid arthritis (RA) and to analyse the contribution of cumulative inflammatory burden and other factors to its development. Design Observational cross-sectional study. Participants Patients with RA and controls matched for age, sex and Body Mass Index. We excluded patients with diabetes. Settings Patients from an RA inception cohort at Hospital Regional Universitario de Málaga, Spain, were recruited between September 2016 and May 2018. Primary and secondary outcome measures IR was evaluated using the homeostasis model assessment for IR and beta-cell function and the quantitative insulin sensitivity check index. Other variables included the cumulative 28-Joint Disease Activity Score (DAS28) with C reactive protein (CRP) body composition and cytokines. Two logistic regression models were constructed to identify factors associated with IR in patients with RA. Results Eighty-nine patients with RA and 80 controls were included. The prevalence of IR was similar in both cases and controls. Inflammatory activity was controlled appropriately in patients during follow-up (mean DAS28 3.1 (0.8)). The presence of IR in patients with RA was associated with obesity (OR 6.01, 95% CI 1.9 to 8.7), higher cumulative DAS28-CRP values during follow-up (OR 2.8, 95% CI 1.3 to 6.0), and higher interleukin-1β levels (OR 1.6, 95% CI 1.1 to 2.4). The second model showed that the risk of IR increased by 10% for each kilogram of excess body fat. Conclusion In patients with well-controlled, established RA, IR is associated mainly with poorer control of inflammation from diagnosis and with obesity, specifically total fat mass.Keywords
Funding Information
- Sociedad Española de Reumatología (Grant for Medical Researchers of the Spanish Found)
- Sociedad Española de Reumatología (Grant of the Spanish Foundation of Rheumatology 20)
This publication has 54 references indexed in Scilit:
- RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean DietNew England Journal of Medicine, 2013
- Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patientsRheumatology International, 2013
- Validation of Dual Energy X-Ray Absorptiometry Measures of Abdominal Fat by Comparison with Magnetic Resonance Imaging in an Indian PopulationPLOS ONE, 2012
- Disease-Modifying Antirheumatic Drugs Increase Serum Adiponectin Levels in Patients With Rheumatoid ArthritisJCR: Journal of Clinical Rheumatology, 2011
- The role of interleukins in insulin resistance and type 2 diabetes mellitusNature Reviews Endocrinology, 2009
- Association of C-Reactive Protein with Surrogate Measures of Insulin Resistance among Nondiabetic US Adults: Findings from National Health and Nutrition Examination Survey 1999–2002Clinical Chemistry, 2007
- Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritisDiabetes & Vascular Disease Research, 2007
- Insulin resistance in patients with rheumatoid arthritis: effect of anti‐TNFα therapyScandinavian Journal of Rheumatology, 2007
- Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2006
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001